ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 137 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,233,340 | -15.2% | 702,900 | +19.1% | 0.01% | -20.0% |
| Q2 2023 | $3,813,338 | -6.4% | 590,300 | +9.2% | 0.01% | -9.1% |
| Q1 2023 | $4,074,616 | -36.0% | 540,400 | -14.1% | 0.01% | -38.9% |
| Q4 2022 | $6,369,744 | +37.7% | 628,800 | +34.4% | 0.02% | +38.5% |
| Q3 2022 | $4,626,000 | +817.9% | 467,700 | +888.8% | 0.01% | +1200.0% |
| Q2 2022 | $504,000 | +111.8% | 47,300 | +93.9% | 0.00% | 0.0% |
| Q1 2022 | $238,000 | -66.3% | 24,400 | +17.3% | 0.00% | -50.0% |
| Q1 2021 | $706,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |